Clinical Trials Sponsored by Lorenz Biotech S.p.A

Total 8 results

Lorenz Biotech S.p.A.

Completed

Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy

Diabetic Neuropathy, Painful

France, Germany, Italy
IRCCS San Raffaele
University Of Perugia; Lorenz Biotech S.p.A.

Completed

Electromagnetic Stimulation (FREMS) in Patients With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

Italy
Siena Biotech S.p.A.

Completed

A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease

Huntington's Disease

United States
Siena Biotech S.p.A.

Completed

Escalating Dose Study in Healthy Volunteers With SEN0014196

Huntington's Disease

United Kingdom
Siena Biotech S.p.A.

Completed

A Phase II Safety and Tolerability Study With SEN0014196

Huntington's Disease

Germany
Larena SAS
CEN Biotech; Luxia Scientific

Completed

Study of the Composition and Bacterial Diversity of the Vaginal Microbiota in Healthy Versus Pathological Conditions (Bacterial Vaginosis) Using a Targeted Metagenomic Approach (RNA 16s) (CEBAM)

Vaginosis, Bacterial

France
Beijing Boren Hospital
Nanjing Legend Biotech Co.

Terminated

LCAR-T2C CAR-T Cells in Relapsed or Refractory CD4+ T Lymphocyte Tumor

T-cell Leukemia | T Cell Lymphoma

China
Siena Biotech S.p.A.
Seventh Framework Programme; European Huntington's Disease Network

Completed

An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 (PADDINGTON)

Huntington Disease

Germany

3

Subscribe